Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toul
Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse DGAP-News: Evotec SE / Key word(s): Miscellaneous 20.04.2021 / 07:30 J.POD (R) 2 EU BIOMANUFACTURING WILL PLAY A KEY ROLE IN ADDRESSING THE NEED FOR THERAPEUTIC ANTIBODIES, INCLUDING THOSE RELATED TO INFECTIOUS DISEASES SUCH AS COVID-19 EVOTEC WILL BE SUPPORTED BY THE FRENCH GOVERNMENT AS WELL AS THE OCCITANIE REGION, BPIFRANCE, THE HAUTE-GARONNE PREFECTURE AND TOULOUSE MÉTROPOLE CONSTRUCTION OF THE J.POD Hamburg, Germany, 20 April 2021: Evotec SE (Frankfurt Stoc...